Skip to content

Virtual Reality for Patient Informed Consent in Neurosurgery

Virtual Reality for Patient Informed Consent in Neurosurgery - a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06627426
Enrollment
34
Registered
2024-10-04
Start date
2024-10-22
Completion date
2025-10-15
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VR-based Informed Consent

Brief summary

The goal of this randomized controlled trial is to evaluate benefits of VR (virtual reality)-based patient informed consent in neurosurgery regarding subjective patient comprehension, patient-doctor relationship and anxiety.

Detailed description

Additionally, the investigators aim to assess the cost-benefit radio as well as feasibility in a clinical routine setting. Considering the increasing patient participation in decision-making, VR could lead to better understanding of complex surgical procedures, improving the perioperative process for both, patient and surgeon, and reduce anxiety.

Interventions

OTHERVR-based patient informed consent

The intervention group will be the on receiving VR-based patient informed consent. One surgeon from the study team will be guiding the patient through their VR model first with demonstration of the technology and the model, afterwards the patient will be enabled to use the VR system by themselves. During the whole process the patient will be able to ask questions. Depending on the planned surgery, the surgical approach as well important anatomical structures will be explained.

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Randomized, open controlled

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients between the age of 18 and 75 * Surgical clipping for intracranial aneurysm, resection of vascular malformations * Craniotomy and Resection of intracranial tumors that can be segmented for VR

Exclusion criteria

* Visual or auditory impairment with no sufficient aid * Patient that had VR informed consent for surgery before * Psychiatric illness, cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Comparison of intensity of anxiety between intervention and control groupone time assessment at day 1Comparison of intensity of physical and cognitive anxiety symptoms will be assessed by the questionnaire Beck Anxiety Inventory (BAI). This questionnaire consists of 21 self-reported items (four-point scale). min score: 39 (minimal anxiety level) max score:174 (severe anxiety)
Comparison of patient doctor relationship between intervention and control groupone time assessment at day 1Comparison of patient doctor relationship will be assessed by PDRQ9 (patient-doctor relationship questionnaire). The questionnaire is a 9-item scale that assesses patients' perception of the relationship with the physician. Items are scored on a 5-point Likert scale ranging from 'not at all appropriate' to 'totally appropriate'. Raw sum scores range from 9 to 45, with higher scores indicating that the patient's perception of the patient-doctor relationship is more favorable.

Countries

Switzerland

Contacts

Primary ContactRaphael Guzman, Prof. Dr.
raphael.guzman@usb.ch+41 61 32 87522

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026